HERNDON, Va., Sept. 24, 2021
/PRNewswire/ -- ePlus inc. (NASDAQ NGS: PLUS –
news) today announced that it has launched an artificial
intelligence (AI) workflow technology bundle, combining hardware,
software and AI implementation services, to help healthcare
organizations accelerate clinical and operational AI projects from
concept to production.
The AI Workflow Accelerator Bundle for Healthcare provides a
complete turn-key platform for AI discovery and visualization,
modeling and experimentation, productization and operations. It
includes GPU-accelerated hardware from NVIDIA or Cisco with
proprietary software from John Snow Labs, implementation services
from ePlus and optional training and model development consulting
services from SFL Scientific.
There are a growing number of highly practical uses for AI in
healthcare settings, yet many organizations struggle with how to
get started assessing what they need, identifying use cases and
implementing the technology. According to a recent survey from
KPMG, 37 percent of healthcare industry executives reported that
the pace at which they are implementing AI is too slow and 47
percent responded that their organizations offer AI training
courses to employees.
The AI Workflow Accelerator Bundle for Healthcare removes these
and other barriers to entry by giving organizations an efficient,
comprehensive package to help tailor their own solution, from
hardware and software to rapid implementation, training and
accelerated data consumption. The bundle takes the guesswork and
uncertainty out of parsing together an AI platform by giving
organizations a pre-bundled solution of technology and training
components that help fast-track modeling, implementation and usage,
helping them more quickly achieve success and hastening access to
rich data insight.
"Utilizing this technology platform allows organizations to more
confidently design, implement and begin using AI in very practical
ways that will accelerate access to actionable, data-driven insight
that helps to solve a variety of problems unique to healthcare
environments," said Ken Farber, president of software,
national partners, marketing and strategy at ePlus. "The AI
Workflow Accelerator Bundle for Healthcare can serve as a powerful
foundation from which organizations can build applications that
help them realize operational efficiencies, enhanced patient
outcomes and improved financial performance as a result of
streamlined information discovery and advanced analytical
capabilities. We're very excited to bring this solution to market
and are proud to work with such high caliber partners to do
so."
"The healthcare industry is being transformed, and the
application of AI is increasingly becoming a game changer in
enhancing both clinician and patient experiences," said
David Talby, chief technology
officer at John Snow Labs. "This bundle leverages a powerful
combination of technology and services that will make it faster and
easier for organizations to put AI to good use while tackling the
unique compliance, terminology, and integration challenges of
healthcare."
"The combination of technology and services available from
ePlus, John Snow Labs, and SFL Scientific is handing organizations
flexible, fast access to smart AI solutions that support the
success and advancement of the healthcare industry," said
Eddie Newland, director of AI
services at SFL Scientific. "Developing AI solutions in highly
regulated industries adds additional layers of scrutiny to an
already complex task. This unique approach should allow healthcare
leaders to feel confident that their organizational goals can be
achieved in a compliant, secure and scalable environment that will
grow as they continue to adopt AI throughout their
organization."
About ePlus inc.
ePlus is a leading
consultative technology solutions provider that helps customers
imagine, implement, and achieve more from their technology.
With the highest certifications from top technology partners and
lifecycle services expertise across key areas including security,
cloud, data center, collaboration, networking and emerging
technologies, ePlus transforms IT from a cost center to a business
enabler. Founded in 1990, ePlus has more than 1,500
associates serving a diverse set of customers in the U.S.,
Europe, and Asia-Pac. The
Company is headquartered at 13595 Dulles Technology Drive,
Herndon, VA, 20171. For more
information, visit www.eplus.com, call 888-482-1122, or email
info@eplus.com. Connect with ePlus on Facebook, LinkedIn,
Twitter and Instagram. ePlus, Where Technology Means
More®.
ePlus®, Where Technology Means
More®, and ePlus products referenced herein
are either registered trademarks or trademarks of ePlus inc. in
the United States and/or other
countries. The names of other companies, products, and
services mentioned herein may be the trademarks of their respective
owners.
About John Snow Labs
John Snow Labs, the AI and NLP
for healthcare company, provides state-of-the-art software, models,
and data to help healthcare and life science
organizations build, deploy, and operate AI projects. The
company is the developer of Spark NLP, the world's most widely
used NLP library in the enterprise, and its award-winning medical
NLP software powers some of the world's leading healthcare and
pharmaceutical companies. The company is the creator and host of
The NLP Summit, further educating and advancing the global AI
community.
About SFL Scientific
FL Scientific is a US-based data
science consulting firm focused on strategy, technology, and
solving business & operational challenges with Artificial
Intelligence (AI). Working with clients of all sizes, industries,
and AI maturity levels, our capabilities range from developing
corporate AI strategy to building custom AI applications at scale.
With a globally connected network of technology and cloud partners,
SFL Scientific's core services include leading cross-functional
efforts across business, IT, and operations. Hundreds of
clients—including S&P100 enterprises, fastest-growing startups,
and government agencies—trust SFL Scientific to create and
accelerate AI initiatives.
For more information, please visit sflscientific.com and connect
with us on LinkedIn & Twitter.
Statements in this press release that are not historical facts
may be deemed to be "forward-looking statements." Actual and
anticipated future results may vary materially due to certain risks
and uncertainties, including, without limitation, the duration and
impact of COVID-19 and the efficacy of vaccine roll-outs, which
could materially adversely affect our financial condition and
results of operations and has resulted worldwide in governmental
authorities imposing numerous unprecedented measures to try to
contain the virus that has impacted and may further impact our
workforce and operations, the operations of our customers, and
those of our respective vendors, suppliers, and partners; national
and international political instability fostering uncertainty and
volatility in the global economy including an economic downturn, an
increase in tariffs or adverse changes to trade agreements,
exposure to fluctuation in foreign currency rates, interest rates
and downward pressure on prices; our ability to successfully
perform due diligence and integrate acquired businesses; the
possibility of goodwill impairment charges in the future; reduction
of vendor incentive programs; significant adverse changes in,
reductions in, or losses of relationships with one or more of our
largest volume customers or vendors; the demand for and acceptance
of, our products and services; our ability to adapt our services to
meet changes in market developments; our ability to implement
comprehensive plans to achieve customer account coverage for the
integration of sales forces, cost containment, asset
rationalization, systems integration and other key strategies; our
ability to reserve adequately for credit losses; our ability to
secure our electronic and other confidential information or that of
our customers or partners and remain secure during a cyber-security
attack; future growth rates in our core businesses; our ability to
protect our intellectual property; the impact of competition in our
markets; the possibility of defects in our products or catalog
content data; our ability to adapt to changes in the IT industry
and/or rapid change in product standards; our ability to realize
our investment in leased equipment; our ability to hire and retain
sufficient qualified personnel; and other risks or uncertainties
detailed in our reports filed with the Securities and Exchange
Commission. All information set forth in this press release
is current as of the date of this release and ePlus undertakes no
duty or obligation to update this information.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/eplus-launches-turn-key-technology-bundle-to-facilitate-adoption-of--artificial-intelligence-by-healthcare-organizations-301384084.html
SOURCE ePlus inc.